First Organoid Intelligence (OI) workshop to form an OI community
Frontiers in Artificial Intelligence · 42 authors, 40 centres
AI SUMMARY
FIDELITY 100%
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
The first Organoid Intelligence (OI) workshop established a multidisciplinary community to explore using brain organoids for biocomputing. The workshop outlined a roadmap for OI, including ethical frameworks, technological challenges, and potential applications in computing and neurological research. The key finding is that OI could revolutionize computing by leveraging the brain's efficiency, but requires careful ethical consideration and standardized protocols.
Full summary
3,354 CHARS
**Background:** The human brain is an extremely efficient computational system, processing vast amounts of information while consuming only 20 watts of power. Recent advances in stem cell technology have led to the development of three-dimensional (3D) brain organoids that recapitulate human brain functionality better than traditional 2D cultures. Organoid Intelligence (OI) aims to harness the innate biological capabilities of brain organoids for biocomputing and synthetic intelligence by interfacing them with computer technology. The first Organoid Intelligence workshop was held at Johns Hopkins University on February 22–24, 2022, to form an OI community and lay the groundwork for OI as a new scientific discipline.
**Methods:** The workshop brought together members of the global scientific community to present and discuss OI across four tracks: ethics, brain organoids, electrophysiology, and data analysis. The workshop included presentations on the current state of organoid technology, ethical considerations, electrophysiological interfacing, and data analysis methods. Workgroup sessions on the second day addressed challenges and strategies, with summaries reported on the third day. The workshop also introduced the Baltimore Declaration toward OI.
**Key Results:** The workshop highlighted several key developments and challenges. In the ethics track, a pilot project (SATORI) conducted 60 interviews with patients and outpatients, showing broad support for organoid research but conditional responses for brain organoids, emphasizing the need for boundaries and thorough consent processes. In the brain organoids track, Alysson Muotri presented cortical organoids that exhibit neuro-oscillations mimicking prenatal to postnatal human brain EEGs. Karl Wahlin discussed retinal organoids as sensory models, and Lena Smirnova presented the BrainSphere model with reproducible size and cellular composition, including myelination. In the electrophysiology track, David Gracias introduced shell MEAs for 3D recording, John Rogers presented 3D mesoscale structures for bioelectronic interfaces, Tim Harris discussed Neuropixels probes with 384 channels across 960 sites, and Tzahi Cohen-Karni introduced Organ-on-e-Chip for 3D recording. In the data analysis track, Brian Caffo emphasized repeatability and validity, Fang Han discussed machine learning for separating meaningful outputs from inputs, and Alex Szalay presented the SciServer for storing petabytes of data. The workshop identified challenges including the need for consistent terminology, defining intelligence in organoids, improving organoid fitness and longevity, and creating standardized benchmarks. The participants agreed on the Baltimore Declaration toward OI.
**Clinical Implications:** OI has the potential to revolutionize computing, neurological research, and drug development. It could be used to study conditions such as Asperger's, impaired neurodevelopment, and dementia, and to develop better treatments. The workshop emphasized the importance of embedded ethics, with ethicists included in research teams. The development of OI could lead to new ways of brain/machine interactions, better clinical outcomes, and improved therapeutics. The establishment of standards and reproducible protocols is critical for the clinical translation of OI technologies.